EAST WINDSOR, N.J.—Sabinsa Corporation's sister company, Sami Labs Ltd., acquired the India-based company KCP Biotech to gain another foothold in the growing biotech market.
This acquisition will help Sami Labs strengthen its product portfolio for world markets. The new facility, spread across five acres in Genome Valley, will be integrated with Sami’s existing Hyderabad facility. The acquisition also adds three natural colors to the Sabinsa product line: red, yellow and orange made from paprika, turmeric and annatto.
With the addition of a modern manufacturing facility, an ISO-certified facility situated at SP Biotech Park Genome Valley and Sami’s second in Hyderabad, the company now has seven manufacturing units, including units in Kunigal, Nelamangala, Dobaspet and Utah. Sabinsa/Sami’s R&D locations include Bengaluru and East Windsor, New Jersey.
"The additional biotech capabilities this acquisition brings will help us move more quickly, bringing to market products and capabilities our dynamic R&D staff are constantly developing," said founder and managing director Muhammed Majeed. “And adding natural colors to our product offerings complements our existing ingredient portfolio, which is having great success in the global supply chain."
Sabinsa will be offering these natural colors to customers in Europe, Japan, Australia, China, United Arab Emirates (UAE), South Africa, Vietnam, Malaysia and the United States.
Earlier this year, Sabinsa received four new international patents.